Biomarkers for Cystic Fibrosis Drug Development

PURPOSE: To provide a review of the status of biomarkers in cystic fibrosis drug development, including regulatory definitions and considerations, a summary of biomarkers in current use with supportive data, current gaps, and future needs. METHODS: Biomarkers are considered across several areas of C...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Cyst Fibros
Glavni autori: Muhlebach, Marianne S., Clancy, JP, Heltshe, Sonya L., Ziady, Assem, Kelley, Tom, Accurso, Frank, Pilewski, Joseph, Mayer-Hamblett, Nicole, Joseloff, Elizabeth, Sagel, Scott D.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5321565/
https://ncbi.nlm.nih.gov/pubmed/28215711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2016.10.009
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items